Back to Search

A Randomized Phase III Trial of Consolidation With Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs. Maintenance Rituximab Alone for Patients With Mantle Cell Lymphoma in Minimal Residual Disease-Negative First Complete Remission

  • Protocol Number: 201710050
  • Principal Investigator: Cashen, Amanda
  • Cancer Types: Leukemia, Myeloma, and Hematologic, Lymphoma

For more information on this trial, contact us here:

[email protected]

Brief Summary

Protocol Interventions